Fundraising FoxAtreo
San Francisco, US · Founded 2021 · Delaware corporation
Find your way into Atreo
Sign up to see every warm intro you have to Atreo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atreo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atreo builds RTSM (Randomization and Trial Supply Management) software for clinical trial teams in the life sciences industry. Its platform supports study deployment across all trial phases with a focus on agility, quality, and reduced supply management costs.
Founders & leadership
Atreo was founded in 2021 by Ryan Harrison and Jon Ball.
RH
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 1 round · 2022
▶$3.8MraisedJun 2022 · 28 investors · Other Health CareRule 506(b)
▶$3.8MraisedJun 2022 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan HarrisonExecutive Officer, Director
- Jonathan BallExecutive Officer, Director
- John RanzExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3.8M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
KorioKorio provides RTSM (Randomization and Trial Supply Management) software for clinical trials, with a focus on experienced project management and continuity throughout the study lifecycle. The company serves clinical operations teams and sponsors managing treatment assignment and supply logistics in regulated pharmaceutical trials.
VeevaVeeva Clinical Platform is a cloud-based suite of connected applications for running clinical trials, covering clinical operations, clinical data, research sites, and patients. It serves biopharma sponsors, clinical research sites, and patients across trial management, data capture, and disclosures.
ReltioReltio is a cloud-native, software-as-a-service (SaaS) data platform that helps enterprises manage and unify master data to deliver business outcomes. It serves Global 2000 companies seeking to accelerate data value and power data-driven decision-making through real-time, trusted data and AI integration.
SuvodaSuvoda provides software solutions for managing complex clinical trials, including therapeutic areas such as oncology, central nervous system disorders, and rare disease. It serves pharmaceutical and clinical research customers, helping remove barriers to trial participation and expand access.
4G Clinical4G Clinical builds technology and delivery services aimed at reducing avoidable delay in clinical trial execution, serving sponsors, CROs, and research sites. The company works within the clinical research and clinical trial supply space to help therapies reach patients faster.
Companies working in the same space as Atreo.
In the news
Frequently asked questions
- What does Atreo do?
- Atreo builds RTSM (Randomization and Trial Supply Management) software for clinical trial teams in the life sciences industry. Its platform supports study deployment across all trial phases with a focus on agility, quality, and reduced supply management costs.
- Who founded Atreo?
- Atreo was founded by Ryan Harrison, Jon Ball in 2021.
- How much funding has Atreo raised?
- Atreo has disclosed $3.8M raised across 1 round.
- Where is Atreo headquartered?
- Atreo is headquartered in San Francisco, US.